Cargando…
Anisomycin has the potential to induce human ovarian cancer stem cell ferroptosis by influencing glutathione metabolism and autophagy signal transduction pathways
Ovarian cancer is a highly malignant gynecological tumor that seriously endangers women's health. Previously, we demonstrated that anisomycin significantly inhibited the activity of ovarian cancer stem cells (OCSCs) in vitro and in vivo. In this study, anisomycin treatment of OCSCs significantl...
Autores principales: | Xiong, Ying, Liu, Te, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197939/ https://www.ncbi.nlm.nih.gov/pubmed/37215446 http://dx.doi.org/10.7150/jca.83355 |
Ejemplares similares
-
Anisomycin has a potential toxicity of promoting cuproptosis in human ovarian cancer stem cells by attenuating YY1/lipoic acid pathway activation
por: Nie, Xiaoli, et al.
Publicado: (2022) -
Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10
por: Chen, Wei, et al.
Publicado: (2022) -
miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression
por: Ling, Lele, et al.
Publicado: (2023) -
Anisomycin Activates Utrophin Upregulation Through a p38 Signaling Pathway
por: Hadwen, Jeremiah, et al.
Publicado: (2018) -
Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA-Meg3/miR-421/PDGFRA axis
por: Ye, Weiping, et al.
Publicado: (2019)